Literature DB >> 19940192

Initiation and progression of axonopathy in experimental autoimmune encephalomyelitis.

Athena M Soulika1, Eunyoung Lee, Erica McCauley, Laird Miers, Peter Bannerman, David Pleasure.   

Abstract

Axonal loss is the principal cause of chronic disability in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE). In C57BL/6 mice with EAE induced by immunization with myelin oligodendrocyte glycoprotein peptide 35-55, the first evidences of axonal damage in spinal cord were in acute subpial and perivascular foci of infiltrating neutrophils and lymphocytes and included intra-axonal accumulations of the endovesicular Toll-like receptor TLR8, and the inflammasome protein NAcht leucine-rich repeat protein 1 (NALP1). Later in the course of this illness, focal inflammatory infiltrates disappeared from the spinal cord, but there was persistent activation of spinal cord innate immunity and progressive, bilaterally symmetric loss of small-diameter corticospinal tract axons. These results support the hypothesis that both contact-dependent and paracrine interactions of systemic inflammatory cells with axons and an innate immune-mediated neurodegenerative process contribute to axonal loss in this multiple sclerosis model.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19940192      PMCID: PMC2990681          DOI: 10.1523/JNEUROSCI.3794-09.2009

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  157 in total

1.  C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE.

Authors:  Andrea Reboldi; Caroline Coisne; Dirk Baumjohann; Federica Benvenuto; Denise Bottinelli; Sergio Lira; Antonio Uccelli; Antonio Lanzavecchia; Britta Engelhardt; Federica Sallusto
Journal:  Nat Immunol       Date:  2009-03-22       Impact factor: 25.606

Review 2.  Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis.

Authors:  Bruce D Trapp; Peter K Stys
Journal:  Lancet Neurol       Date:  2009-03       Impact factor: 44.182

3.  Blockade of glutamate release from microglia attenuates experimental autoimmune encephalomyelitis in mice.

Authors:  Jin Shijie; Hideyuki Takeuchi; Izumi Yawata; Yohei Harada; Yoshifumi Sonobe; Yukiko Doi; Jianfeng Liang; Li Hua; Satoko Yasuoka; Yan Zhou; Mariko Noda; Jun Kawanokuchi; Tetsuya Mizuno; Akio Suzumura
Journal:  Tohoku J Exp Med       Date:  2009-02       Impact factor: 1.848

4.  Glutamate receptors on myelinated spinal cord axons: II. AMPA and GluR5 receptors.

Authors:  Mohamed Ouardouz; Elaine Coderre; Gerald W Zamponi; Shameed Hameed; Xinghua Yin; Bruce D Trapp; Peter K Stys
Journal:  Ann Neurol       Date:  2009-02       Impact factor: 10.422

5.  Localizing central nervous system immune surveillance: meningeal antigen-presenting cells activate T cells during experimental autoimmune encephalomyelitis.

Authors:  Pia Kivisäkk; Jaime Imitola; Stine Rasmussen; Wassim Elyaman; Bing Zhu; Richard M Ransohoff; Samia J Khoury
Journal:  Ann Neurol       Date:  2009-04       Impact factor: 10.422

Review 6.  The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis.

Authors:  Luigi Franchi; Tatjana Eigenbrod; Raúl Muñoz-Planillo; Gabriel Nuñez
Journal:  Nat Immunol       Date:  2009-03       Impact factor: 25.606

7.  Glutamate receptors on myelinated spinal cord axons: I. GluR6 kainate receptors.

Authors:  Mohamed Ouardouz; Elaine Coderre; Ajoy Basak; Andrew Chen; Gerald W Zamponi; Shameed Hameed; Renata Rehak; Xinghua Yin; Bruce D Trapp; Peter K Stys
Journal:  Ann Neurol       Date:  2009-02       Impact factor: 10.422

8.  Expression of human amyloid precursor protein in rat cortical neurons inhibits calcium oscillations.

Authors:  Susana Ferrao Santos; Nathalie Pierrot; Nicole Morel; Philippe Gailly; Christian Sindic; Jean-Noël Octave
Journal:  J Neurosci       Date:  2009-04-15       Impact factor: 6.167

Review 9.  The challenge of multiple sclerosis: how do we cure a chronic heterogeneous disease?

Authors:  Howard L Weiner
Journal:  Ann Neurol       Date:  2009-03       Impact factor: 10.422

10.  Immunoglobulins and complement in postmortem multiple sclerosis tissue.

Authors:  Michael H Barnett; John D E Parratt; Eun-Sook Cho; John W Prineas
Journal:  Ann Neurol       Date:  2009-01       Impact factor: 10.422

View more
  64 in total

1.  Modulation of Rho-Rock signaling pathway protects oligodendrocytes against cytokine toxicity via PPAR-α-dependent mechanism.

Authors:  Ajaib S Paintlia; Manjeet K Paintlia; Avtar K Singh; Inderjit Singh
Journal:  Glia       Date:  2013-07-10       Impact factor: 7.452

2.  Transfer of myelin-reactive th17 cells impairs endogenous remyelination in the central nervous system of cuprizone-fed mice.

Authors:  Emily G Baxi; Joseph DeBruin; Dominique M Tosi; Inna V Grishkan; Matthew D Smith; Leslie A Kirby; Hayley J Strasburger; Amanda N Fairchild; Peter A Calabresi; Anne R Gocke
Journal:  J Neurosci       Date:  2015-06-03       Impact factor: 6.167

Review 3.  Toll-like receptor signaling in neural plasticity and disease.

Authors:  Eitan Okun; Kathleen J Griffioen; Mark P Mattson
Journal:  Trends Neurosci       Date:  2011-03-16       Impact factor: 13.837

4.  Aged hind-limb clasping experimental autoimmune encephalomyelitis models aspects of the neurodegenerative process seen in multiple sclerosis.

Authors:  Lindsay S Cahill; Monan Angela Zhang; Valeria Ramaglia; Heather Whetstone; Melika Pahlevan Sabbagh; Tae Joon Yi; Laura Woo; Thomas S Przybycien; Marina Moshkova; Fei Linda Zhao; Olga L Rojas; Josephine Gomes; Stefanie Kuerten; Jennifer L Gommerman; John G Sled; Shannon E Dunn
Journal:  Proc Natl Acad Sci U S A       Date:  2019-10-22       Impact factor: 11.205

5.  Nonspecific labeling limits the utility of Cre-Lox bred CST-YFP mice for studies of corticospinal tract regeneration.

Authors:  Rafer Willenberg; Oswald Steward
Journal:  J Comp Neurol       Date:  2015-08-10       Impact factor: 3.215

Review 6.  Origins and significance of astrogliosis in the multiple sclerosis model, MOG peptide EAE.

Authors:  Monica Moreno; Fuzheng Guo; Emily Mills Ko; Peter Bannerman; Athena Soulika; David Pleasure
Journal:  J Neurol Sci       Date:  2013-01-05       Impact factor: 3.181

7.  Thalamus Degeneration and Inflammation in Two Distinct Multiple Sclerosis Animal Models.

Authors:  Nina Wagenknecht; Birte Becker; Miriam Scheld; Cordian Beyer; Tim Clarner; Tanja Hochstrasser; Markus Kipp
Journal:  J Mol Neurosci       Date:  2016-08-04       Impact factor: 3.444

8.  Apolipoprotein E mediation of neuro-inflammation in a murine model of multiple sclerosis.

Authors:  Soomin Shin; Katharine A Walz; Angela S Archambault; Julia Sim; Bryan P Bollman; Jessica Koenigsknecht-Talboo; Anne H Cross; David M Holtzman; Gregory F Wu
Journal:  J Neuroimmunol       Date:  2014-03-29       Impact factor: 3.478

9.  HIFα Regulates Developmental Myelination Independent of Autocrine Wnt Signaling.

Authors:  Sheng Zhang; Yan Wang; Jie Xu; Bokyung Kim; Wenbin Deng; Fuzheng Guo
Journal:  J Neurosci       Date:  2020-11-18       Impact factor: 6.167

10.  An ανβ3 integrin-binding peptide ameliorates symptoms of chronic progressive experimental autoimmune encephalomyelitis by alleviating neuroinflammatory responses in mice.

Authors:  Fan Zhang; Jing Yang; Hong Jiang; Shu Han
Journal:  J Neuroimmune Pharmacol       Date:  2014-02-28       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.